2don MSN
William Blair Maintains Market Perform Rating on uniQure (QURE) Despite AMT-130 Approval Uncertainty
Qure N.V. (NASDAQ:QURE) ranks among the most oversold biotech stocks to invest in. William Blair reaffirmed its Market Perform rating for uniQure N.V. (NASDAQ:QURE) on November 11 while the company ...
Adobe Inc. (NASDAQ:ADBE) is an affordable blue-chip stock to buy. On November 10, William Blair analyst Jake Roberge ...
2don MSN
William Blair Maintains Hold Rating on Legend Biotech (LEGN) Despite Carvykti Label Safety Concerns
Legend Biotech Corporation (NASDAQ:LEGN) has overcome previous manufacturing capacity concerns, is currently fulfilling ...
Fintel on MSN
William Blair Initiates Coverage of Coterra Energy (CTRA) with Outperform Recommendation
Fintel reports that on November 26, 2025, William Blair initiated coverage of Coterra Energy (NYSE:CTRA) with a Outperform ...
On November 17, 2025, William Blair’s Andrew Jeffrey reiterated his “Buy” rating on Block, Inc. (NYSE:XYZ). The bullish ...
The latest crypto slide has created an attractive entry point for the two companies' stocks, with core USDC and bitcoin ...
Biohaven Ltd. (NYSE:BHVN) is one of the best small-cap biotech stocks to buy according to analysts. On November 11, 2025, ...
CHICAGO & NEW YORK--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, announced today the addition ...
CHICAGO--(BUSINESS WIRE)--William Blair today announced the launch of the William Blair Small-Mid Cap Value Fund (ISMVX). Portfolio managers William Heaphy, CFA, and Matthew Fleming, CFA, will ...
What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback